Two Sigma Investments, LP Autolus Therapeutics PLC Transaction History

Two Sigma Investments, LP

$42.8 Billion
Q1 2025

A detailed history of Two Sigma Investments, LP transactions in Autolus Therapeutics PLC stock. As of the latest transaction made, Two Sigma Investments, LP holds 395,443 shares of AUTL stock, worth $806,703. This represents 0.0% of its overall portfolio holdings.

Number of Shares

395,443

Previous 906,767 56.39%

Holding current value

$806,703

Previous $2.13 Million 71.27%

% of portfolio

0.0%

Previous 0.01%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$1.55 - $2.68 $792,552 - $1.37 Million	-511,324 Reduced 56.39%	395,443 $612,000
Q4 2024 Feb 14, 2025	BUY	$2.18 - $4.8 $380,377 - $837,528	174,485 Added 23.83%	906,767 $2.13 Million
Q3 2024 Nov 14, 2024	SELL	$3.38 - $4.69 $924,882 - $1.28 Million	-273,634 Reduced 27.2%	732,282 $2.66 Million
Q2 2024 Aug 14, 2024	BUY	$3.33 - $5.68 $2.59 Million - $4.41 Million	777,074 Added 339.57%	1,005,916 $3.5 Million
Q1 2024 May 15, 2024	SELL	$5.39 - $7.29 $153,151 - $207,138	-28,414 Reduced 11.05%	228,842 $1.46 Million
Q4 2023 Feb 14, 2024	BUY	$2.13 - $6.63 $88,524 - $275,549	41,561 Added 19.27%	257,256 $1.66 Million
Q3 2023 Nov 14, 2023	SELL	$2.32 - $3.36 $215,973 - $312,789	-93,092 Reduced 30.15%	215,695 $502,000
Q2 2023 Aug 14, 2023	BUY	$1.64 - $3.21 $353,170 - $691,267	215,348 Added 230.47%	308,787 $734,000
Q1 2023 May 15, 2023	BUY	$1.75 - $2.25 $104,543 - $134,412	59,739 Added 177.27%	93,439 $171,000
Q4 2022 Feb 14, 2023	BUY	$1.74 - $3.27 $58,638 - $110,199	33,700 New	33,700 $64,000
Q2 2021 Aug 16, 2021	SELL	$4.78 - $7.96 $368,729 - $614,034	-77,140 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$5.49 - $9.36 $423,498 - $722,030	77,140 New	77,140 $442,000
Q4 2020 Feb 16, 2021	SELL	$8.13 - $12.79 $269,729 - $424,333	-33,177 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$11.64 - $16.3 $386,180 - $540,785	33,177 New	33,177 $386,000

Others Institutions Holding AUTL

# of Institutions

Shares Held

163M

Call Options Held

Put Options Held

88.3K

View Full List

About Autolus Therapeutics plc

Ticker AUTL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 90,909,800
Market Cap $185M
Description
Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer. The company's clinical-stage programs include obecabtagene autoleucel (AUTO1), a CD19-targeting programmed T cell investigational therapy that is in Phase 1b/2 clinical trial for the treatment of adult ALL; AUTO1/22, which...

More about AUTL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Account

Two Sigma Investments, LP Autolus Therapeutics PLC Transaction History